Corden Pharma
Plankstadt, DE · Caponago, IT · Boulder, CO
Program data pending ClinicalTrials.gov matching
· Last scored 2026-04-29
81.0
Signal Score
✓ FDA Inspections (2)
○ Clinical Trials
○ SEC Filings
✓ Press (1)
✓ EMA GMP (9)
○ MHRA GMP
Quick Facts: Corden Pharma
- Signal Score
- 81.0/100 (as of 2026-04-29)
- Quality Compliance
- 98.7/100
- Headquarters
- Plankstadt, DE · Caponago, IT · Boulder, CO
- Modalities
- mRNA, Oligonucleotide, Biologics
- Active Programs
- No ClinicalTrials.gov matches confirmed
- Data Sources
- FDA Data Dashboard, ClinicalTrials.gov, SEC EDGAR, press monitoring
- Scored By
- CDMO Signal — independent CDMO intelligence platform
About Corden Pharma
Manufactured lipids for BioNTech COVID vaccine.
Signal Score & Pillar Breakdown
Quality Compliance
98.7
FDA Inspections2 on record
Warning Letters0
Last InspectionNo Action Indicated (NAI) (2025-11-14)
EMA GMP Certificates9 on record
Operations
—
No ClinicalTrials.gov facility matches confirmed for this manufacturer.
Programs
— no verified data
Sponsors— no verified data
ModalitiesmRNA, Oligonucleotide, Biologics
No clinical trial matches found for this manufacturer
Operational score requires ClinicalTrials.gov data
Data sourced from ClinicalTrials.gov, FDA, SEC EDGAR, and verified press only. No unverified estimates shown.
Financial Stability
68.0
Parent company: ICIG
Financial assessment: 68.0/100
Source: SEC EDGAR, press monitoring
Profile-based financial assessment
SEC FilingsPrivate company
Parent company: ICIG
Financial assessment: 68.0/100
Capacity
63.0
3 manufacturing sites
Sites: Plankstadt, Germany, Caponago, Italy, Boulder, CO
Source: SEC EDGAR, press monitoring, company profiles
3 manufacturing sites
Recent Press1 articles
3 manufacturing sites
Corden Pharma FDA Inspection History
2025-11
2025-10
NAI
VAI
OAI
| Date | Site | Type | Observations | Classification |
|---|---|---|---|---|
| 2025-11-14 | Boulder, Colorado | Drug Quality Assurance | No | No Action Indicated (NAI) |
| 2025-10-23 | Fairfield, New Jersey | Drug Quality Assurance | Yes | Voluntary Action Indicated (VAI) |
Source: FDA Data Dashboard · Retrieved Jul 04, 2026
Corden Pharma FDA 483 Findings 3 observations · 2025-08-15 → 2025-10-23 ?
By subsystem
By severity
- 2 — Minor: 3
- Repeat observations: 0
Most severe findings
-
Written procedures not established/followed
"Written procedures are not followed for the cleaning and maintenance of equipment, including utensils, used in the manufacture, processing, packing or holding of a drug product."
-
Verification activity - appropriate
"You did not conduct an appropriate supplier verification activity."
-
Verification activity frequency
"You did not determine the frequency of conducting the verification activities to provide adequate assurances that a food you obtain from a foreign supplier is produced in compliance with processes and procedures that provide the required level of public health protection."
Corden Pharma EMA GMP Compliance 9 certificates
2025-10
2025-10
2025-05
2025-03
2025-03
2025-03
2025-03
2025-03
2025-03
Compliant
Non-Compliant
| Certificate | Site | Country | Inspection Date | Status |
|---|---|---|---|---|
| DE_BW_01_GMP_2025_0261 | Corden Pharma GmbH | Germany | 2025-10-15 | COMPLIANT |
| DE_BW_01_GMP_2025_0260 | Corden Pharma GmbH | Germany | 2025-10-15 | COMPLIANT |
| 2025_HPF_FR_090 | Corden Pharma Chenove | France | 2025-05-15 | COMPLIANT |
| IT/80/H/2025 | Corden Pharma S.p.A. | Italy | 2025-03-28 | COMPLIANT |
| IT/121/H/2026 | Corden Pharma S.p.A. | Italy | 2025-03-28 | COMPLIANT |
| F022/S1/MH/001/2026 | Corden Pharma Lisbon S.A. | Portugal | 2025-03-21 | COMPLIANT |
| F022/S2/MH/001/2026 | Corden Pharma Lisbon S.A. | Portugal | 2025-03-21 | COMPLIANT |
| F022/S2/ME/001/2026 | Corden Pharma Lisbon S.A. | Portugal | 2025-03-21 | COMPLIANT |
| F022/S1/ME/001/2026 | Corden Pharma Lisbon S.A. | Portugal | 2025-03-21 | COMPLIANT |
Source: EMA EudraGMDP · Retrieved Jul 04, 2026
Recent News 1 articles
CordenPharma Colorado Partners with BioMed Realty on Peptide Development Lab Expansion - CHEManager
CordenPharma Colorado Partners with BioMed Realty on Peptide Development Lab Expansion CHEManager.
Frequently Asked Questions About Corden Pharma
How many FDA inspections does Corden Pharma have on record?
CDMO Signal tracks 2 FDA inspections for Corden Pharma, sourced from the FDA inspection database. See the full inspection history above.
Has Corden Pharma received an FDA warning letter?
CDMO Signal has no FDA warning letters on record for Corden Pharma.
Does Corden Pharma hold EMA or MHRA GMP certificates?
CDMO Signal tracks 9 EMA GMP certificates for Corden Pharma.
What is Corden Pharma's CDMO Signal Score?
Corden Pharma has a Signal Score of 81/100, based on quality, operations, financial stability, and capacity data.
Evaluating Corden Pharma for a manufacturing program?
Use the free AI matchmaker to compare Corden Pharma against other CDMOs by FDA, EMA, and clinical-trial data — no login required.
Find & compare CDMOs →
Represent this organization? Contact us to verify or update this profile.
See all CDMOs in:
Similar CDMOs
Curia (RNA/Advanced)
Albany, NY · Albuquerque, NM
Signal Score: 79.4
mRNA, Oligonucleotide, Biologics
Roche / Genentech (Internal Manufacturing & CustomBiotech)
Basel, Switzerland
Biologics, mAb, Cell Therapy, Gene Therapy (AAV), Oligonucleotide, mRNA, Small Molecule
Pfizer CentreOne
Kalamazoo, MI · McPherson, KS
Signal Score: 91.5
Biologics, mRNA
Ajinomoto Bio-Pharma Services
San Diego, CA · Osaka, JP
Signal Score: 85.6
Oligonucleotide, Biologics, AAV
Merck KGaA / MilliporeSigma (CDMO)
Darmstadt, DE · St. Louis, MO
Signal Score: 81.8
mRNA, Biologics, Cell Therapy